抗高血糖治疗相关安全问题的最新情况
Update on Safety Issues Related to Antihyperglycemic Therapy.
作者信息
Carpio Gandahari Rosa A, Fonseca Vivian A
出版信息
Diabetes Spectr. 2014 May;27(2):92-100. doi: 10.2337/diaspect.27.2.92.
Abstract
The American Diabetes Association emphasizes the importance of individualized patient care in the management of diabetes. One of the important considerations in choosing an antihyperglycemic agent is its side-effect and safety profile. This article reviews the common and clinically significant side effects of each class of agents, including ways to prevent and overcome their occurrence.
摘要
美国糖尿病协会强调在糖尿病管理中个体化患者护理的重要性。选择抗高血糖药物时的一个重要考虑因素是其副作用和安全性。本文回顾了各类药物常见且具有临床意义的副作用，包括预防和克服其发生的方法。
相似文献
1
Update on Safety Issues Related to Antihyperglycemic Therapy.抗高血糖治疗相关安全问题的最新情况
Diabetes Spectr. 2014 May;27(2):92-100. doi: 10.2337/diaspect.27.2.92.
2
Pharmacotherapeutic considerations and treatment patterns of antihyperglycemic agents for diabetic nephropathy: a review of the literature.治疗糖尿病肾病的抗高血糖药物的药物治疗考虑因素和治疗模式：文献复习。
Eur Rev Med Pharmacol Sci. 2023 Dec;27(24):12058-12069. doi: 10.26355/eurrev_202312_34804.
3
Patient-reported perceptions of side effects of antihyperglycemic medication and adherence to medication regimens in persons with diabetes mellitus.糖尿病患者报告的降糖药物副作用认知及药物治疗方案依从性
Clin Ther. 2007 Jan;29(1):177-80. doi: 10.1016/j.clinthera.2007.01.014.
4
The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.糖尿病及相关心脏代谢危险因素对成员的影响：优化结局的策略。
J Manag Care Pharm. 2008 Feb;14(1 Suppl C):S2-14; quiz 15-6. doi: 10.18553/jmcp.2008.14.S1-B.1.
5
Analysis of Patents Issued in China for Antihyperglycemic Therapies for Type 2 Diabetes Mellitus.中国2型糖尿病抗高血糖治疗相关专利分析
Front Pharmacol. 2019 May 21;10:586. doi: 10.3389/fphar.2019.00586. eCollection 2019.
6
Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.中重度斑块状银屑病的紫外线光疗管理：一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(27):1-66. Epub 2009 Nov 1.
7
Discontinuation of antihyperglycemic therapy and clinical outcomes after acute myocardial infarction in older patients with diabetes.老年糖尿病患者急性心肌梗死后降糖治疗的中断与临床结局
Circ Cardiovasc Qual Outcomes. 2010 May;3(3):236-42. doi: 10.1161/CIRCOUTCOMES.109.887620. Epub 2010 Mar 30.
8
Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes.糖尿病患者使用降糖药物与癌症风险
Curr Oncol Rep. 2023 Jan;25(1):29-40. doi: 10.1007/s11912-022-01344-7. Epub 2022 Nov 29.
9
Individualized HbA Goals, and Patient Awareness and Attainment of Goals in Type 2 Diabetes Mellitus: A Real-World Multinational Survey.个体化 HbA1c 目标与 2 型糖尿病患者的知晓和达标情况：一项真实世界的跨国调查。
Adv Ther. 2022 Feb;39(2):1016-1032. doi: 10.1007/s12325-021-01985-3. Epub 2021 Dec 24.
10
Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association.美国心脏协会关于 2 型糖尿病成人心血管危险因素综合管理的科学声明
Circulation. 2022 Mar;145(9):e722-e759. doi: 10.1161/CIR.0000000000001040. Epub 2022 Jan 10.
引用本文的文献
1
Duodenal Dual-Wavelength Photobiomodulation Improves Hyperglycemia and Hepatic Parameters with Alteration of Gut Microbiome in Type 2 Diabetes Animal Model.十二指肠双波长光生物调节改善 2 型糖尿病动物模型的高血糖和肝参数，并改变肠道微生物组。
Cells. 2022 Nov 3;11(21):3490. doi: 10.3390/cells11213490.
2
Action mechanism of hypoglycemic principle 9-(R)-HODE isolated from cortex lycii based on a metabolomics approach.基于代谢组学方法的枸杞皮层中分离出的降血糖成分9-(R)-羟基十八碳二烯酸的作用机制
Front Pharmacol. 2022 Oct 21;13:1011608. doi: 10.3389/fphar.2022.1011608. eCollection 2022.
3
Asian Best Practices for Care of Diabetes in Elderly (ABCDE).亚洲老年糖尿病护理最佳实践（ABCDE）。
Rev Diabet Stud. 2022 Jun 30;18(2):100-134. doi: 10.1900/RDS.2022.18.100.
4
Phytochemical Screening and Antidiabetic, Antihyperlipidemic, and Antioxidant Effects of Decne. In Diabetic Mice.Decne. 对糖尿病小鼠的植物化学筛选及其抗糖尿病、抗高血脂和抗氧化作用
Front Pharmacol. 2021 Apr 8;12:643242. doi: 10.3389/fphar.2021.643242. eCollection 2021.
5
Does Weight Gain Associated with Thiazolidinedione Use Negatively Affect Cardiometabolic Health?与噻唑烷二酮类药物使用相关的体重增加是否会对心脏代谢健康产生负面影响？
J Obes Metab Syndr. 2017 Jun;26(2):102-106. doi: 10.7570/jomes.2017.26.2.102. Epub 2017 Jun 30.
6
Hypoglycemic and hypolipidemic activity of aqueous leaf extract of L.罗勒叶水提取物的降血糖和降血脂活性
PeerJ. 2018 Feb 20;6:e4389. doi: 10.7717/peerj.4389. eCollection 2018.
7
Hypoglycemic and hypolipidemic activities of aqueous extract of flowers from Nycantus arbor-tristis L. in male mice.夜香树花水提取物对雄性小鼠的降血糖和降血脂活性
BMC Complement Altern Med. 2015 Aug 19;15:289. doi: 10.1186/s12906-015-0807-0.
本文引用的文献
1
Standards of medical care in diabetes--2014.2014年糖尿病医疗护理标准
Diabetes Care. 2014 Jan;37 Suppl 1:S14-80. doi: 10.2337/dc14-S014.
2
Economic costs of diabetes in the U.S. in 2012.2012 年美国糖尿病的经济成本。
Diabetes Care. 2013 Apr;36(4):1033-46. doi: 10.2337/dc12-2625. Epub 2013 Mar 6.
3
Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial.达格列净添加治疗二甲双胍控制不佳的 2 型糖尿病：一项随机、双盲、安慰剂对照的 102 周试验。
BMC Med. 2013 Feb 20;11:43. doi: 10.1186/1741-7015-11-43.
4
Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial.二甲双胍治疗伴有周围神经病变的 2 型糖尿病：一项随机试验。
Am J Med. 2013 Feb;126(2):141-9. doi: 10.1016/j.amjmed.2012.06.022. Epub 2012 Dec 5.
5
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study.度拉糖肽每周 1 次与艾塞那肽每周 1 次治疗 2 型糖尿病患者的疗效比较（DURATION-6）：一项随机、开放标签研究。
Lancet. 2013 Jan 12;381(9861):117-24. doi: 10.1016/S0140-6736(12)61267-7. Epub 2012 Nov 7.
6
Comparing diabetes drugs--helping clinical decisions?比较糖尿病药物——有助于临床决策吗？
Lancet. 2013 Jan 12;381(9861):93-4. doi: 10.1016/S0140-6736(12)61576-1. Epub 2012 Nov 7.
7
A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer.一项荟萃分析报告了 exenatide 和 liraglutide 的严重不良事件：急性胰腺炎和癌症。
Diabetes Res Clin Pract. 2012 Nov;98(2):271-84. doi: 10.1016/j.diabres.2012.09.008. Epub 2012 Sep 23.
8
Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis.噻唑烷二酮类药物的使用与 2 型糖尿病患者膀胱癌风险的关系：一项荟萃分析。
CMAJ. 2012 Sep 4;184(12):E675-83. doi: 10.1503/cmaj.112102. Epub 2012 Jul 3.
9
Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysis.吡格列酮治疗糖尿病患者膀胱癌风险增加：一项荟萃分析。
Diabetes Res Clin Pract. 2012 Oct;98(1):159-63. doi: 10.1016/j.diabres.2012.05.006. Epub 2012 Jun 16.
10
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study.吡格列酮的使用与 2 型糖尿病患者膀胱癌风险：巢式病例对照研究。
BMJ. 2012 May 30;344:e3645. doi: 10.1136/bmj.e3645.
Zotero 插件